Referenzen (Quelle: Dystract-Antrag 2014)

Abecasis GR, Altshuler D et al. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-1073.

Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Movement disorders : official journal of the Movement Disorder Society 2013;28:863-873.

Albanese A, Sorbo FD, Comella C, et al. Dystonia rating scales: Critique and recommendations. Mov Disord 2013;28:874-883.

Altenmüller E, Baur V, Hofmann A, Lim VK, Jabusch HC. Musician's cramp as manifestation of maladaptive brain plasticity: arguments from instrumental differences. Ann N Y Acad Sci 1252: 259-265. (2012)

Altenmüller E, Müller D. A model of task-specific focal dystonia. Neural Networks 48: 25-31 (2013)

Antony G, Eggert K, Franke S, Oertel WH. Die elektronische Kommunikationsstruktur des Kompetenznetzes Parkinson. Telemedizinführer Deutschland, Hrsg. A. Jäckel, 2006

Argyelan M, Carbon M, Niethammer M, Ulug AM, Voss HU, Bressman SB, Dhawan V, Eidelberg D. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci. 2009;29(31):9740-7

Arif B, Kumar KR, Seibler P, et al. A novel OPA3 mutation revealed by exome sequencing: an example of reverse phenotyping. JAMA Neurol 2013;70:783-787.

Asmus F, Hjermind LE, Dupont E, et al. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. Brain 2007;130:2736-2745.

Asmus F, Salih F, Hjermind LE, et al. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann Neurol 2005;58:792-797.

Baasch AL, Huning I, Gilissen C, et al. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities. Epilepsia 2014;55:e25-29.

Balash Y, Giladi N. Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. European journal of neurology : the official journal of the European Federation of Neurological Societies 2004;11:361-370.

Bamshad MJ, Ng SB, Bigham AW, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 2011;12:745-755.

Baumer T, Demiralay C, Hidding U, et al. Abnormal plasticity of the sensorimotor cortex to slow repetitive transcranial magnetic stimulation in patients with writer's cramp. Mov Disord 2007;22:81-90.

Baur V, Jabusch HC, Altenmüller E. Behavioral factors influence the phenotype of musician’sdystonia. Mov Disord 26: 1780-1781 (2011)

Beck S, Houdayer E, Richardson SP, Hallett M. The role of inhibition from the left dorsal premotor cortex in right-sided focal hand dystonia. Brain stimulation 2009;2:208-214.

Becker et al. TMF-Schriftenreihe Band 8. Regulatorische Anforderungen an Medizinprodukte. Einführung und Handlungshilfen - von klinischer Bewertung bis HTA. 2008

Belluscio L, Gold GH, Nemes A, Axel R. Mice deficient in G(olf) are anosmic. Neuron 1998;20:69-81.

Ben-Shlomo Y, Camfield L, Warner T. What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry 2002;72:608-614.

Bock, A, Kühn, AA, Trahms L and Sander-Thömmes T. Validity of subthalamic-cortical coherency observed in patients with Parkinson's disease. Biomedizinische Technik. 2013; 58(2):157-64

Brans JW, Lindeboom R, Snoek JW, et al. Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology 1996;46:1066-1072.

Bressman SB, Sabatti C, Raymond D, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology 2000;54:1746-1752.

Brighina F, Romano M, Giglia G, et al. Effects of cerebellar TMS on motor cortex of patients with focal dystonia: a preliminary report. Exp Brain Res 2009;192:651-656.

Brücke C, Huebl J, Schönecker T, Neumann WJ, Yarrow K, Kupsch A, Blahak C, Lütjens G, Brown P, Krauss JK, Schneider GH, Kühn AA. Scaling of movement is related to pallidale ? osscillations in patients with dystonia. J Neurosci. 2012;32(3):1008-19.

Cacciola F, Farah JO, Eldridge PR, Byrne P, Varma TK. Bilateral deep brain stimulation for cervical dystonia: long-term outcome in a series of 10 patients. Neurosurgery 2010;67:957-963.

Calderon DP, Fremont R, Kraenzlin F, Khodakhah K: The neural substrates of rapid-onset Dystonia-Parkinsonism. Nat Neurosci 14:357-365, 2011

Camfield L, Ben-Shlomo Y, Warner TT. Impact of cervical dystonia on quality of life. Mov Disord 2002;17:838-841.

Cao S, Hewett JW, Yokoi F, et al. Chemical enhancement of torsinA function in cell and animal models of torsion dystonia. Disease models & mechanisms. May-Jun 2010;3(5-6):386-396.

Carbon M, Argyelan M, Ghilardi MF, et al. Impaired sequence learning in dystonia mutation carriers: a genotypic effect. Brain 2011;134:1416-1427.

Carri AD, Onorati M, Lelos MJ, et al. Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons. Development. Jan 15 2013;140(2):301-312.

Cayrol C, Lacroix C, Mathe C, et al. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Blood 2007;109:584-594.

Chen CC, Kühn AA, Hoffmann KT et al. Oscillatory pallidal local field potential activity correlates with involuntary EMG in dystonia. Neurology. 2006;66:418-20.

Comella CL, Jankovic J, Shannon KM, et al. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 2005;65:1423-1429.

Comella CL, Jankovic J, Truong DT, et al. Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. Journal of Neurological Sciences 2011;308:103-109.

Corvol JC, Valjent E, Pascoli V, et al. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants. Neuropsychopharmacology 2007;32:1109-1121.

Cramer SC, Sampat A, Haske-Palomino M, Nguyen S, Procaccio V, Hermanowicz N. Increased prevalence of val(66)met BDNF genotype among subjects with cervical dystonia. Neurosci Lett 2010;468:42-45.

Defazio G, Abbruzzese G, Livrea P, Berardelli A. Epidemiology of primary dystonia. Lancet neurology 2004;3:673-678.

Defazio G, Gigante AF. The environmental epidemiology of primary dystonia. Tremor Other Hyperkinet Mov (N Y) 2013;3.

Devine MJ, Ryten M, Vodicka P, et al. Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nature communications. 2011;2:440.

Dieni S, Matsumoto T, Dekkers M, et al. BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons. Journal of Cell Biology 2012;196:775-788.

Doss S, Lohmann K, Seibler P, et al. Recessive dystonia-ataxia syndrome in a Turkish family caused by a COX20 (FAM36A) mutation. J Neurol 2014;261:207-212.

Eggert K, Antony G, Franke S, Oertel WH. The GEPARD Data Collection Model – Protected Data Collection for the Gene Bank Parkinson's Disease Germany of the Competence Network on Parkinson's Disease. it 2007, 49: 367-373

Eggert K, Wüllner U, Antony G, Gasser T, Janetzky B, Klein C, Schöls L, Oertel WH. Data protection in biomaterial banks for Parkinson’s disease research: The model of GEPARD (Gene Bank Parkinson’s Disease Germany). Movement disorder, 2007; 22: 611-61

Eltahawy HA, Saint-Cyr J, Poon YY, Moro E, Lang AE, Lozano AM. Pallidal deep brain stimulation in cervical dystonia: clinical outcome in four cases. Can J Neurol Sci 2004;31:328-332.

Enders L, Spector J Altenmüller E, Schmidt A, Klein C, Jabusch HC. Musician’s Dystonia and Comorbid Anxiety: Two Sides of One Coin? Mov Disord 25: 539-42 (2011)

Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. Journal of neurology 2000;247:787-792.

Feng G, Mellor RH, Bernstein M, et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000;28:41-51.

Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nature reviews Neurology 2011;7:616-630.

Foo JN, Liu JJ, Tan EK. Whole-genome and whole-exome sequencing in neurological diseases. Nat Rev Neurol 2012;8:508-517.

Fuchs T, Gavarini S, Saunders-Pullman R, et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009;41:286-288.

Fuchs T, Saunders-Pullman R, Masuho I, et al. Mutations in GNAL cause primary torsion dystonia. Nature genetics. Jan 2013;45(1):88-92.

Furuya S, Nitsche M, Paulus W, Altenmüller E. Surmounting Retraining Limits in Musicians’ Dystonia by Transcranial Stimulation. Annals of Neurology 2014: DOI: 10.1002/ana.24151

Furuya S, Nitsche M, Paulus W, Altenmüller E. Surmounting Retraining Limits in Musicians’ Dystonia by Transcranial Stimulation. Annals of Neurology 2014: DOI: 10.1002/ana.24151

Gavarini S, Cayrol C, Fuchs T, et al. Direct interaction between causative genes of DYT1 and DYT6 primary dystonia. Annals of neurology. Oct 2010;68(4):549-553.

Gerfen CR. Indirect-pathway neurons lose their spines in Parkinson disease. Nat Neurosci 2006;9:157-158.

Gernert M, Bennay M, Fedrowitz M, Rehders JH, Richter A: Altered discharge pattern of basal ganglia output neurons in an animal model of idiopathic dystonia. J Neurosci 22:7244-7253, 2002

Gilissen C, Hoischen A, Brunner HG, Veltman JA. Unlocking Mendelian disease using exome sequencing. Genome Biol 2011;12:228.

Goebel, Scheller. TMF-Schriftenreihe Band 7. Verwertungsrechte in der vernetzten medizinischen Forschung. 2008

Goodchild RE, Kim CE, Dauer WT. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron. Dec 22 2005;48(6):923-932.

Groen JL, Ritz K, Velseboer DC, et al. Association of BDNF Met66Met polymorphism with arm tremor in cervical dystonia. Movement disorders : official journal of the Movement Disorder Society 2012;27:796-797.

Groppa S, Schlaak B, Münchau A, Werner-Petroll N, Dünnweber J, Bäumer T, van Nuenen BF, Siebner HR. The human dorsal premotor cortex facilitates the excitability of ipsilateral primary motor cortex via a short latency cortico- cortical route. Hum Brain Mapp 2012a;33:419-430.

Groppa S, Werner-Petroll N, Münchau A, Deuschl G, Ruschworth MF, Siebner HR. A novel dual-site transcranial magnetic stimulation paradigm to probe fast facilitatory inputs from ipsilateral dorsal premotor cortex to primary motor cortex. Neuroimage 2012b;62:500-9.

Haack TB, Hogarth P, Kruer MC, et al. Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X- linked dominant form of NBIA. Am J Hum Genet 2012;91:1144-1149.

Hallett M. Neurophysiology of dystonia: The role of inhibition. Neurobiology of disease 2011;42:177-184.

Harnischmacher, Ihle, Berger, Goebel, Scheller. TMF-Schriftenreihe Band 3. Checkliste und Leitfaden zur Patienteneinwilligung. Grundlagen und Anleitung für die klinische Forschung. 2006

Hefter H, Benecke R, Erbguth F, Jost W, Reichel G, Wissel J. An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ open 2013;3.Brin MF, Lew MF Adler CH. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999;53:1431-1439.

Herrojo-Ruiz M, Senghaas P, Grossbach M, Jabusch HC, Bangert M, Hummel F, Gerloff Ch, Altenmüller E. Defective inhibition and inter-regional phase synchronization in pianists with musician's dystonia (MD): an EEG study. Human Brain Mapping 30: 2689-2700 (2009)

Herrojo-Ruiz M, Strübing F, Jabusch HC, Altenmüller E. EEG oscillatory patterns are associated with error prediction during music performance and are altered in musician's dystonia. Neuroimage 55:1791-803 (2011)

Herve D, Le Moine C, Corvol JC, et al. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci 2001;21:4390-4399.

Hewett J, Ziefer P, Bergeron D, Naismith T, Boston H, Slater D, et al: TorsinA in PC12 cells: localization in the endoplasmic reticulum and response to stress. J Neurosci Res 72:158-168, 2003

Hewett JW, Zeng J, Niland BP, Bragg DC, Breakefield XO. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiology of disease. Apr 2006;22(1):98-111.

Hirschmann J, Hartmann CJ, Butz M et al. A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson's disease. Brain. 2013;136(Pt 12):3659-70.

Hirschmann J, Özkurt TE, Butz M et al. Distinct oscillatory STN-cortical loops revealed by simultaneous MEG and local field potential recordings in patients with Parkinson's disease. Neuroimage. 2011;55(3):1159-68.

Hoffland BS, Bologna M, Kassavetis P, et al. Cerebellar theta burst stimulation impairs eyeblink classical conditioning. The Journal of physiology 2012;590:887-897.

Hoffland BS, Kassavetis P, Bologna M, et al. Cerebellum-dependent associative learning deficits in primary dystonia are normalized by rTMS and practice. Eur J Neurosci 2013;38:2166-2171.

Huang YZ, Edwards MJ, Bhatia KP, Rothwell JC. One-Hz repetitive transcranial magnetic stimulation of the premotor cortex alters reciprocal inhibition in DYT1 dystonia. Mov Disord 2004;19:54-59.

Huang YZ, Lu CS, Rothwell JC, et al. Modulation of the disturbed motor network in dystonia by multisession suppression of premotor cortex. PloS one 2012;7:e47574.

Hung SW, Hamani C, Lozano AM, et al. Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology 2007;68:457-459.

Ioannou C, Altenmüller E. Psychological Characteristics in Musician’s Dystonia: A New Diagnostic Classification. Neuropsychologia (in press)

Ip CW, Kohl B, Kleinschnitz C, Reuss B, Nave KA, Kroner A, et al: Origin of CD11b+ macrophage-like cells in the CNS of PLP-overexpressing mice: Low influx of haematogenous macrophages and unchanged blood-brain-barrier in the optic nerve. Molecular and Cellular Neuroscience 38:489-494, 2008

Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, Fischer S, et al: Immune Cells Contribute to Myelin Degeneration and Axonopathic Changes in Mice Overexpressing Proteolipid Protein in Oligodendrocytes. The Journal of Neuroscience 26:8206-8216, 2006

Ip CW, Kroner A, Crocker PR, Nave K-A, Martini R: Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiology of Disease 25:105-111, 2007

Ip CW, Kroner A, Groh J, Huber M, Klein D, Spahn I, et al: Neuroinflammation by cytotoxic T-lymphocytes impaires retrograde axonal transport in an oligodendrocyte mutant mouse PLoS ONE 7(8):e42554. Epub 2012 Aug 8., 2012

Ip CW, Kroner A, Kohl B, Wessig C, Martini R: Tacrolimus (FK506) causes disease aggravation in models for inherited peripheral myelinopathies. Neurobiology of Disease 33:207-212, 2009

Isaias IU, Marotta G, Pezzoli G, Sabri O, Schwarz J, Crenna P, et al: Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease. BMC Neurol 11:88, 2011

Isaias IU, Moisello C, Marotta G, Schiavella M, Canesi M, Perfetti B, et al: Dopaminergic striatal innervation predicts interlimb transfer of a visuomotor skill. J Neurosci 31:14458-14462, 2011

Isaias IU, Volkmann J, Marzegan A, Marotta G, Cavallari P, Pezzoli G: The influence of dopaminergic striatal innervation on upper limb locomotor synergies. PLoS One 7:e51464, 2012

Jabusch HC, Altenmüller E. Anxiety as an aggravating factor during onset of focal Dystonia in musicians: Med. Probl. Perf. Arts: 19: 75-81 (2004)

Jabusch HC, Müller SV, Altenmüller E. High levels of perfectionism and anxiety in musicians with focal dystonia. Mov Disord. 19: 990-991. (2004)

Jankovic J, Tsui J, Bergeron C. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism & related disorders 2007;13:411-416.

Jokhi V, Ashley J, Nunnari J, et al. Torsin mediates primary envelopment of large ribonucleoprotein granules at the nuclear envelope. Cell reports 2013;3:988-995.

Kaiser FJ, Osmanoric A, Rakovic A, et al. The dystonia gene DYT1 is repressed by the transcription factor THAP1 (DYT6). Annals of neurology. Oct 2010;68(4):554-559.

Kamm C, Fischer H, Garavaglia B, Kullmann S, Sharma M, Schrader C, Grundmann K, Klein C, Borggraefe I, Lobsien E, Kupsch A, Nardocci N, Gasser T. Susceptibility to DYT1 dystonia in European patients is modified by the D216H polymorphism. Neurology. 2008;70:2261-2262.

Kamm C, Uflacker N, Asmus F, Schrader C, Wolters A, Wittstock M, Pahnke J, Gasser T, Volkmann J, Münchau A, Hagenah J, Benecke R, Klein C, Lohmann K. No evidence for THAP1/DYT6 variants as disease modifiers in DYT1 dystonia. Mov Disord 2011;26:2136-2137.

Kasten M, Hagenah J, Graf J, et al. Cohort Profile: a population-based cohort to study non-motor symptoms in parkinsonism (EPIPARK). Int J Epidemiol 2013;42:128-128k.

Keller A, Westenberger A, Sobrido MJ, García-Murias M, Domingo A, Sears RL, Lemos RR, Ordoñez-Ugalde A, Nicolas G, da Cunha JE, Rushing EJ, Hugelshofer M, Wurnig MC, Kaech A, Reimann R, Lohmann K, Dobri?i? V, Carracedo A, Petrovi? I, Miyasaki JM, Abakumova I, Mäe MA, Raschperger E, Zatz M, Zschiedrich K, Klepper J, Spiteri E, Prieto JM, Navas I, Preuss M, Dering C, Jankovi? M, Paucar M, Svenningsson P, Saliminejad K, Khorshid HR, Novakovi? I, Aguzzi A, Boss A, Le Ber I, Defer G, Hannequin D, Kosti? VS, Campion D, Geschwind DH, Coppola G, Betsholtz C, Klein C, Oliveira JR. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet 2013;45:1077-1082.

Kessler KR, Skutta M, Benecke R. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. Journal of neurology 1999;246:265-274.

Kiehntopf, Böer. TMF-Schriftenreihe Band 5. Biomaterialbanken - Checkliste zur Qualitätssicherung. 2008

Kim CE, Perez A, Perkins G, Ellisman MH, Dauer WT. A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc Natl Acad Sci U S A 2010;107:9861-9866.

Kiss ZH, Doig-Beyaert K, Eliasziw M, Tsui J, Haffenden A, Suchowersky O. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain : a journal of neurology 2007;130:2879-2886.

Klatte K, Kirschstein T, Otte D, Pothmann L, Müller L, Tokay T, Kober M, Uebachs M, Zimmer A, Beck H. Impaired D-serine-mediated cotransmission mediates cognitive dysfunction in epilepsy. J Neurosci. 2013;33(32):13066-80.

Klein C, Marras, C, Münchau, A. Dystonia Overview. In: GeneReviews [online]. Available at 2014.

Klein C. Genetics in dystonia. Parkinsonism & related disorders. Jan 2014;20 Suppl 1:S137-142.

Kock N, Naismith TV, Boston HE, Ozelius LJ, Corey DP, Breakefield XO, et al: Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier. Hum Mol Genet 15:1355-1364, 2006

Krause M, Fogel W, Kloss M, Rasche D, Volkmann J, Tronnier V. Pallidal stimulation for dystonia. Neurosurgery 2004;55:1361-1370.

Krauss JK, Pohle T, Weber S, Ozdoba C, Burgunder JM. Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia. Lancet 1999;354:837-838.

Krawczak, Freudigmann (Hrsg.). TMF-Schriftenreihe Band 9. Qualitätsmanagement von Hochdurchsatz-Genotypisierungsdaten. 2011

Kriks S, Shim JW, Piao J, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature. Dec 22 2011;480(7378):547-551.

Kroeger J, Bäumer T, Jonas M, Rothwell JC, Siebner HR, Münchau A. Charting the excitability of premotor to motor connections while withholding or initiating a selected movement. Eur J Neurosci 2010;32:1771-1779.

Kühn AA, Huebl J. Safety of transcranial magnetic stimulation for the newer generation of deep brain stimulators. Parkinsonism Relat Disord 2011;17:647-8.

Kühn AA, Kempf F, Brücke C et al. High frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson’s disease in parallel with improvement in motor performance. J Neurosci. 2008. 28(24):6165-73.

Kühn AA, Meyer BU, Trottenberg T, Brandt SA, Schneider GH, Kupsch A. Modulation of motor cortex excitability by pallidal stimulation in patients with severe dystonia. Neurology 2003;60:768-74.

Kumar H, Jog M: Peripheral Trauma Induced Dystonia or Post-Traumatic Syndrome? The Canadian Journal of Neurological Sciences 38:22-29, 2011

Kumar KR, Lohmann K, Masuho I, et al. Mutations in GNAL: A Novel Cause of Craniocervical Dystonia. JAMA Neurol 2014.

Kupsch A, Benecke R, Muller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978-1990.

Leblois A, Reese R, Labarre D, Hamann M, Richter A, Boraud T, et al: Deep brain stimulation changes basal ganglia output nuclei firing pattern in the dystonic hamster. Neurobiol Dis 38:288-298, 2010

Litvak V, Eusebio A, Jha A et al. Movement-related changes in local and long-range synchronization in Parkinson's disease revealed by simultaneous magnetoencephalography and intracranial recordings. J Neurosci. 2012;32(31):10541-53.

Litvak V, Jha A, Eusebio A et al. Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease. Brain. 2011;134(Pt 2):359-74.

Liu X, Wang S, Yianni J et al. The sensory and motor representation of synchronized oscillations in the globus pallidus in patients with primary dystonia. Brain 2008;131:1562-73.

Lohmann K, Klein C. Genetics of dystonia: what's known? What's new? What's next? Mov Disord 2013;28:899-905.

Lohmann K, Schmidt A, Schillert A, Winkler S, Albanese A, Baas F, Bentivoglio AR, Borngräber F, Brüggemann N, Defazio G, Del Sorbo F, Deuschl G, Edwards MJ, Gasser T, Gómez-Garre P, Graf J, Groen JL, Grünewald A, Hagenah J, Hemmelmann C, Jabusch HC, Kaji R, Kasten M, Kawakami H, Kostic VS, Liguori M, Mir P, Münchau A, Ricchiuti F, Schreiber S, Siegesmund K, Svetel M, Tijssen MA, Valente EM, Westenberger A, Zeuner KE, Zittel S, Altenmüller E, Ziegler A, Klein C. Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? Mov Disord 2013, vorab online publiziert.

Lohmann K, Uflacker N, Erogullari A, et al. Identification and functional analysis of novel THAP1 mutations. Eur J Hum Genet 2012;20:171-175.

Lohmann K, Wilcox R, Winkler S, Ramirez A, Rakovic A, Park J, Arns B, Lohnau T, Groen J, Kasten M, Brüggemann N, Hagenah J, Schmidt A, Kaiser FJ, Kumar KR, Zschiedrich K, Alvarez-Fischer D, Altenmüller E, Ferbert A, Lang A, Münchau A, Kostic V, Simonyan M, Agzarian M, Ozelius LJ, Langeveld APM, Sue CM, Tijssen M, Klein C: Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene. Ann Neurol 2013;73: 537–545.

Lu H, Park H, Poo MM. Spike-timing-dependent BDNF secretion and synaptic plasticity. Philosophical transactions of the Royal Society of London Series B, Biological sciences 2014;369:20130132.

Marras C, Lohmann K, Lang A, Klein C. Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. Neurology 2012;78:1016-1024.

Matsumoto T, Rauskolb S, Polack M, et al. Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nature neuroscience 2008;11:131-133.

Matsuzaki Y, Oue M, Hirai H. Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter. J Neurosci Methods 2014;223:133-143.

McNaught KS, Kapustin A, Jackson T, et al. Brainstem pathology in DYT1 primary torsion dystonia. Ann Neurol 2004;56:540-547.

Mehler-Wex C, Kölch M, Kirchheiner J, Antony G, Fegert JM, Gerlach M. Drug Monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy. Child and Adolescent Psychiatry and Mental Health. 2009, 3-14

Misra VP, Ehler E, Zakine B, Maisonobe P, Simonetta-Moreau M. Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study. BMJ open 2012;2.

Mok KY, Schneider SA, Trabzuni D, et al. Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel. Movement disorders : official journal of the Movement Disorder Society 2014;29:245-251.

Morais VA, Haddad D, Craessaerts K, De Bock P-J, Swerts J, Vilain S, Aerts L, Overbergh L, Grünewald A, Seibler P, Klein C, Gevaert K, Verstreken P, De Strooper B. PINK1 loss of function mutations affect Complex I activity via NdufA10 ubiquinone uncoupling. Science 2014;344:203-207.

Muller J, Kemmler G, Wissel J, et al. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. Journal of neurology 2002;249:842-846.

Muller L, Tokay T, Porath K, Kohling R, Kirschstein T. Enhanced NMDA receptor-dependent LTP in the epileptic CA1 area via upregulation of NR2B. Neurobiology of disease. Jun 2013;54:183-193.

Nery FC, Armata IA, Farley JE, et al. TorsinA participates in endoplasmic reticulum-associated degradation. Nature communications. 2011;2:393.

Neumann WJ, Huebl J, Brücke C, Ruiz MH, Kupsch A, Schneider GH, Kühn AA. Enhanced low-frequency oscillatory activity of the subthalamic nucleus in a patient with dystonia. Mov Disord. 2012 Jul; 27(8):1063-6.

Neumann, W.-J., Bock, A., Jha, A. et al. Kortiko-subthalamische oszillatorische Konnektivität in Patienten mit idiopathischem Parkinson-Syndrom Klin Neurophysiol 2014; 45 - P73 DOI: 10.1055/s-0034-1371286, abstract.

Neychev VK, Gross RE, Lehéricy S, Hess EJ, Jinnah HA: The functional neuroanatomy of dystonia. Neurobiology of Disease 42:185-201, 2011

Nonnemacher, Weiland, Stausberg. TMF-Schriftenreihe Band 4. Datenqualität in der medizinischen Forschung. Leitlinie zum adaptiven Management von Datenqualität in Kohortenstudien und Registern. 2007

Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ, 3rd. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988;3:188-194.

Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nature reviews Neuroscience 2013;14:7-23.

Peterson DA, Berque P, Jabusch HC, Altenmüller E, Frucht S. Rating scales for musician's dystonia: the state of the art. Neurology. 2013 Aug 6;81(6):589-98. doi: 10.1212/WNL.0b013e31829e6f72.

Phukan J, Albanese A, Gasser T, Warner T: Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. The Lancet Neurology 10:1074-1085, 2011

Pirio Richardson S, Beck S, Bliem B, Hallett M. Abnormal dorsal premotor-motor inhibition in writer's cramp. Mov Disord 2014;29:797-803.

Prudente CN, Hess EJ, Jinnah HA. Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience 2014;260:23-35.

Puehringer D, Orel N, Luningschror P, et al. EGF transactivation of Trk receptors regulates the migration of newborn cortical neurons. Nat Neurosci 2013;16:407-415.

Quartarone A, Rizzo V, Terranova C, et al. Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia. Brain 2009;132:2871-2877.

Rakovic A, Shurkewitsch K, Seibler P, Grünewald A, Zanon A, Hagenah J, Krainc D, Klein C. Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons. J Biol Chem 2013;288:2223-2237.

Rauskolb S, Zagrebelsky M, Dreznjak A, et al. Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 2010;30:1739-1749.

Reese R, Gruber D, Schoenecker T, et al. Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation. Mov Disord 2011;26:691-698.

Reese R, Leblois A, Steigerwald F, Potter-Nerger M, Herzog J, Mehdorn HM, et al: Subthalamic deep brain stimulation increases pallidal firing rate and regularity. Exp Neurol 229:517-521, 2011

Reng, Debold, Specker, Pommerening. TMF-Schriftenreihe Band 1. Generische Lösungen zum Datenschutz für die Forschungsnetze in der Medizin. 2006

Rose AE, Zhao C, Turner EM, Steyer AM, Schlieker C. Arresting a Torsin ATPase reshapes the endoplasmic reticulum. J Biol Chem 2014;289:552-564.

Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I, et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO molecular medicine. May 2012;4(5):380-395.

Saunders-Pullman R, Shriberg J, Shanker V, Bressman SB. Penetrance and expression of dystonia genes. Adv Neurol 2004;94:121-125.

Schiebler S, Schmidt A, Zittel S, Bäumer T, Gerloff C, Klein C, Münchau A. Arm tremor in cervical dystonia – is it a manifestation of dystonia or essential tremor? Mov Disord 2011;26:1789-1792.

Schmidt A, Jabusch HC, Altenmüller E, Enders L, Saunders-Pullman, R., Bressman, S-B, Münchau A, Klein C, Hagenah J.: Phenotypic spectrum of musician's dystonia: a task-specific disorder? In: Movement Disorders 15: 546-549 (2011).

Schmidt A, Jabusch H-C, Altenmüller E, Hagenah J, Brüggemann N, Lohmann K, Enders L, Kramer PL, Saunders-Pullman R, Bressman SB, Münchau A, Klein C. Etiology of musician’s dystonia: Familial or environmental? Neurology 2009;72:1248-1254.

Schmidt A, Jabusch HC, Altenmüller E, Kasten M, Klein C. Challenges of making music: What causes musician’s dystonia? JAMA Neurol. 2013 Nov 1;70(11):1456-9. doi: 10.1001/jamaneurol.2013.3931.

Seibler P, Graziotto J, Heong H, Simunovic F, Klein C, Krainc D. Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci 2011;31:5970-5976.

Sendtner M. TDP-43: multiple targets, multiple disease mechanisms? Nat Neurosci 2011;14:403-405.

Sendtner M. Therapy development in spinal muscular atrophy. Nat Neurosci 2010;13:795-799.

Sharott A, Grosse P, Kühn AA et al. Is the synchronization between pallidal and muscle activity in primary dystonia due to peripheral afferance or a motor drive? Brain 2008;131(2):473-484.

Shashidharan P, Sandu D, Potla U, et al. Transgenic mouse model of early-onset DYT1 dystonia. Hum Mol Genet 2005;14:125-133.

Shi Y, Kirwan P, Livesey FJ. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nature protocols. Oct 2012;7(10):1836-1846.

Silberstein P, Kühn AA, Kupsch A et al. Patterning of globus pallidus local field potentials differs between Parkinson's disease and dystonia. Brain. 2003. 126: 2597-2608.

Simon, Paslack, Robienski, Goebel, Krawczak. TMF-Schriftenreihe Band 2. Biomaterialbanken. Rechtliche Rahmenbedingungen. 2006

Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009;41:1308-1312.

Simpson DM, Blitzer A, Brashear A, et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70:1699-1706.

Sommer M, Ruge D, Tergau F, Beuche W, Altenmüller E, Paulus W. Spatial distribution of intracortical inhibition and facilitation in focal dystonia. Mov. Disord. 17: 1017-1025 (2002).

Stausberg J, Altmann U, Antony G, Drepper J, Sax U, Schütt A. Registers for networked medical research in Germany. App Clin Inf 2010; 1(4), 408-418

Stausberg J, Nonnemacher M, Weiland D, Antony G, Neuhäuser M. Management of Data Quality - Development of a Computer-Mediated Guideline. In: Hasman A, Haux R, van der Lei J, De Clercq E, Roger France FH, eds. Ubiquity: Technologies for Better Health in Aging Societies. Amsterdam: IOS, 2006: 477-82

Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord 2012;27:1789-1796.

Stroet A, Buckow K, Stürner K, Gold R, Antony G. Das Datenmodell des Kompetenznetzes Multiple Sklerose. E-Health 2012, 112-122

Svetel MV, Djuric G, Novakovic I, et al. A common polymorphism in the brain-derived neurotrophic factor gene in patients with adult-onset primary focal and segmental dystonia. Acta neurologica Belgica 2013;113:243-245.

Tang JK, Moro E, Mahant N, Hutchison WD, Lang AE, Lozano AM, et al: Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease. J Neurophysiol 98:720-729, 2007

Teo JT, van de Warrenburg BP, Schneider SA, Rothwell JC, Bhatia KP. Neurophysiological evidence for cerebellar dysfunction in primary focal dystonia. J Neurol Neurosurg Psychiatry 2009;80:80-83.

Torres GE, Sweeney AL, Beaulieu JM, Shashidharan P, Caron MG: Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A 101:15650-15655, 2004

Trottenberg T, Volkmann J, Deuschl G, et al. Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology 2005;64:344-346.

van Vugt FT, Boullet L, Jabusch HC, Altenmüller E. Musician's dystonia in pianists: Long-term evaluation of retraining and other therapies. Parkinsonism Relat Disord. 2013 Aug 30. doi:pii: S1353-8020(13)00303-9.

Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet 2012;13:565-575.

Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005;352:459-467.

Volkmann J, Mueller J, Deuschl G, et al. Pallidal neurostimulation in patients with medication-refractory cervical dystonia - a sham-controlled randomized trial. submitted to Lancet Neurology (currently review of revised version) 2014.

Volkmann J, Neurologie fdLdDGf. Dystonie. In: Diener HC, Weimar C, eds. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Thieme, 2012.

Volkmann J, Wolters A, Kupsch A, et al. Pallidal deep brain stimulation in patients with primary generalized or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol 2012;11:1029-1038.

Volkmann J, Wolters A, Kupsch A, Müller J, Kühn AA et al. Pallidal deep brain stimulation in patients with primary generalized or segmental dystonia: 5-year follow up of a randomized trial. Lancet Neurol. 2012 Dec;11(12):1029-38.

Wakabayashi-Ito N, Doherty OM, Moriyama H, et al. Dtorsin, the Drosophila ortholog of the early-onset dystonia TOR1A (DYT1), plays a novel role in dopamine metabolism. PLoS One 2011;6:e26183.

Weissbach A, Kasten M, Grunewald A, et al. Prominent psychiatric comorbidity in the dominantly inherited movement disorder myoclonus?dystonia. Parkinsonism Relat Disord 2013;19:422-425.

Wenning GK, Kiechl S, Seppi K, et al. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study. Lancet neurology 2005;4:815-820.

Wiese S, Jablonka S, Holtmann B, et al. Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc Natl Acad Sci U S A 2007;104:17210-17215.

Wilson BK, Hess EJ. Animal models for dystonia. Movement disorders : official journal of the Movement Disorder Society. Jun 15 2013;28(7):982-989.

Wüllner U, Franke S, Antony G, Eggert K. Genbank Parkinson-Krankheit Deutschland (GEPARD). Nervenheilkunde 2007; 26: 246-250

Wüllner U, Schmitz-Hübsch T, Abele M, Antony G, Bauer P, Eggert K on behalf of the CNP. Features of probable Multiple System Atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicenter registry of the German Competence Network on Parkinson’s disease. J Neural Transm 2007; 9:1161-1165

Wüllner U, Schmitz-Hubsch T, Antony G et al. Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing. Eur J Neurol 2007; 14:1405-1408

Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.

Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001;29:66-69.

Zittel S, Moll CKE, Brüggemann N, Tadic V, Hamel W, Kasten M, Lohmann K, Lohnau T, Winkler S, Gerloff C, Schönweiler R, Hagenah H, Klein C, Münchau A, Schneider SA. Clinical, neuroimaging and electrophysiological assessment of three DYT6 dystonia families. Mov Disord 2010;25:2405-2412.